文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2008 年欧洲癌症发病率和死亡率的估计。

Estimates of cancer incidence and mortality in Europe in 2008.

机构信息

International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France.

出版信息

Eur J Cancer. 2010 Mar;46(4):765-81. doi: 10.1016/j.ejca.2009.12.014. Epub 2010 Jan 29.


DOI:10.1016/j.ejca.2009.12.014
PMID:20116997
Abstract

Up-to-date statistics on cancer occurrence and outcome are essential for the planning and evaluation of programmes for cancer control. Since the relevant information for 2008 is not generally available as yet, we used statistical models to estimate incidence and mortality data for 25 cancers in 40 European countries (grouped and individually) in 2008. The calculations are based on published data. If not collected, national rates were estimated from national mortality data and incidence and mortality data provided by local cancer registries of the same or neighbouring country. The estimated 2008 rates were applied to the corresponding country population estimates for 2008 to obtain an estimate of the numbers of cancer cases and deaths in Europe in 2008. There were an estimated 3.2 million new cases of cancer and 1.7 million deaths from cancer in 2008. The most common cancers were colorectal cancers (436,000 cases, 13.6% of the total), breast cancer (421,000, 13.1%), lung cancer (391,000, 12.2%) and prostate cancer (382,000, 11.9%). The most common causes of death from cancer were lung cancer (342,000 deaths, 19.9% of the total), colorectal cancer (212,000 deaths, 12.3%), breast cancer (129,000, 7.5%) and stomach cancer (117,000, 6.8%).

摘要

最新的癌症发病和死亡统计数据对于癌症控制规划和评估至关重要。由于目前还无法获得 2008 年的相关信息,我们使用统计模型估算了 40 个欧洲国家(分组和单独)2008 年 25 种癌症的发病率和死亡率。这些计算基于已发表的数据。对于没有收集到的数据,采用全国死亡率数据和相同或邻近国家的地方癌症登记处提供的发病率和死亡率数据进行估算。将估算的 2008 年发病率应用于相应的 2008 年国家人口估计数,以获得 2008 年欧洲癌症病例和死亡人数的估计数。2008 年估计有 320 万例新癌症病例和 170 万例癌症死亡。最常见的癌症是结直肠癌(43.6 万例,占总数的 13.6%)、乳腺癌(42.1 万例,占 13.1%)、肺癌(39.1 万例,占 12.2%)和前列腺癌(38.2 万例,占 11.9%)。癌症死亡的最常见原因是肺癌(34.2 万例死亡,占总数的 19.9%)、结直肠癌(21.2 万例死亡,占 12.3%)、乳腺癌(12.9 万例,占 7.5%)和胃癌(11.7 万例,占 6.8%)。

相似文献

[1]
Estimates of cancer incidence and mortality in Europe in 2008.

Eur J Cancer. 2010-1-29

[2]
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Eur J Cancer. 2013-2-26

[3]
Estimates of cancer incidence and mortality in Europe in 1995.

Eur J Cancer. 2002-1

[4]
Estimates of the cancer incidence and mortality in Europe in 2006.

Ann Oncol. 2007-3

[5]
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.

Eur J Cancer. 2018-8-9

[6]
Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.

Cancer. 2013-12-16

[7]
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

Epidemiol Prev. 2016

[8]
The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers.

Eur J Cancer. 2021-11

[9]
Italian cancer burden by broad geographical area.

Tumori. 2007

[10]
Cancer incidence and mortality patterns in South Eastern Europe in the last decade: gaps persist compared with the rest of Europe.

Eur J Cancer. 2012-12-19

引用本文的文献

[1]
Comparative efficacy of certoparin, enoxaparin, and combined thromboprophylaxis on thromboembolic events after glioblastoma resection: a prospective observational study.

Sci Rep. 2025-7-1

[2]
Dualistic role of ZEB1 and ZEB2 in tumor progression.

Biol Direct. 2025-3-20

[3]
Topological Descriptors of Colorectal Cancer Drugs and Characterizing Physical Properties Via QSPR Analysis.

Int J Anal Chem. 2025-2-15

[4]
Harnessing Radiation for Nanotechnology: A Comprehensive Review of Techniques, Innovations, and Application.

Nanomaterials (Basel). 2024-12-21

[5]
International perspectives on LI-RADS.

Abdom Radiol (NY). 2024-12-19

[6]
The role of microalgal extracts and their combination with tamoxifen in the modulation of breast cancer immunotherapy (Review).

Mol Clin Oncol. 2024-11-1

[7]
Diagnostic Value of MRI Compared to Histopathological Results in Differentiating Benign from Malignant Ovarian Masses.

Maedica (Bucur). 2024-3

[8]
Evaluation of Stages, Treatment Protocols, and Outcomes of Colorectal Cancer among West Bank Patients.

J Clin Med. 2024-4-15

[9]
Phytochemicals for Cancer Treatment: An Update on Plant-Derived Anti-Cancer Compounds and their Mechanisms of Action.

Curr Top Med Chem. 2024-3-27

[10]
Hepatocellular carcinoma patients serum modulates the regenerative capacities of adipose mesenchymal stromal cells.

Heliyon. 2024-2-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索